Log In
Print this Print this


Also known as: Affitope AD01

  Manage Alerts
Collapse Summary General Information
Company Affiris AG
DescriptionVaccine against beta amyloid
Molecular Target Beta amyloid
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat mild to moderate Alzheimer's disease (AD)
Regulatory Designation
PartnerGlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today